Published in J Virol on August 01, 1995
Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. J Virol (1996) 2.51
Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry. J Virol (2005) 1.85
Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. J Virol (1998) 1.56
Specificity and affinity of binding of herpes simplex virus type 2 glycoprotein B to glycosaminoglycans. J Virol (1997) 1.39
From essential to beneficial: glycoprotein D loses importance for replication of bovine herpesvirus 1 in cell culture. J Virol (1997) 1.12
Synthesis, processing, and oligomerization of bovine herpesvirus 1 gE and gI membrane proteins. J Virol (1996) 1.10
Infectivity of a pseudorabies virus mutant lacking attachment glycoproteins C and D. J Virol (1998) 1.00
The receptor-binding domain of pseudorabies virus glycoprotein gC is composed of multiple discrete units that are functionally redundant. J Virol (1996) 0.99
Infection of Chinese hamster ovary cells by pseudorabies virus. J Virol (1999) 0.95
Attachment but not penetration of bovine herpesvirus 1 is necessary to induce apoptosis in target cells. J Virol (1998) 0.92
Glycoprotein Bb, the N-terminal subunit of bovine herpesvirus 1 gB, can bind to heparan sulfate on the surfaces of Madin-Darby bovine kidney cells. J Virol (1996) 0.90
Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence. J Virol (2000) 0.89
BHV-1: new molecular approaches to control a common and widespread infection. Mol Med (1999) 0.88
Glycoprotein D-independent infectivity of pseudorabies virus results in an alteration of in vivo host range and correlates with mutations in glycoproteins B and H. J Virol (2001) 0.87
Identification and characterization of duck plague virus glycoprotein C gene and gene product. Virol J (2010) 0.86
A UL47 gene deletion mutant of bovine herpesvirus type 1 exhibits impaired growth in cell culture and lack of virulence in cattle. J Virol (2010) 0.85
Novel entry pathway of bovine herpesvirus 1 and 5. J Virol (1998) 0.85
Restoration of function of carboxy-terminally truncated pseudorabies virus glycoprotein B by point mutations in the ectodomain. J Virol (2001) 0.83
Identification of cell surface molecules that interact with pseudorabies virus. J Virol (1996) 0.83
Bovine herpesvirus 1 glycoprotein B does not productively interact with cell surface heparan sulfate in a pseudorabies virion background. J Virol (1997) 0.78
Phosphorylation of Bovine Herpesvirus 1 VP8 Plays a Role in Viral DNA Encapsidation and Is Essential for Its Cytoplasmic Localization and Optimal Virion Incorporation. J Virol (2016) 0.75
Antibodies against Lewis antigens inhibit the binding of human norovirus GII.4 virus-like particles to saliva but not to intestinal Caco-2 cells. Virol J (2016) 0.75
A 2,5-Dihydroxybenzoic Acid-Gelatin Conjugate: The Synthesis, Antiviral Activity and Mechanism of Antiviral Action Against Two Alphaherpesviruses. Viruses (2015) 0.75
Susceptibility of bovine antigen-presenting cells to infection by bovine herpesvirus 1 and in vitro presentation to T cells: two independent events. J Virol (1999) 0.75
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell (1987) 11.56
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell (1991) 8.99
Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta (1971) 6.67
Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol (1991) 5.14
Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J Virol (1988) 4.13
Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev (1991) 3.93
Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature (1984) 3.80
Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells. J Virol (1990) 3.35
Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors. J Virol (1988) 3.33
Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus. J Virol (1990) 3.09
Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol (1994) 2.83
Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies. J Virol (1985) 2.75
RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc Natl Acad Sci U S A (1994) 2.49
Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration. J Virol (1992) 2.32
Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion. J Virol (1984) 2.21
Herpes simplex virus glycoproteins associated with different morphological entities projecting from the virion envelope. J Gen Virol (1987) 2.13
Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J Virol (1993) 1.78
Glycoproteins gIII and gp50 play dominant roles in the biphasic attachment of pseudorabies virus. Virology (1993) 1.72
Cell-specific kinetics and efficiency of herpes simplex virus type 1 entry are determined by two distinct phases of attachment. Virology (1994) 1.68
BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface. Virology (1991) 1.63
Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. J Virol (1988) 1.61
Herpes simplex virus glycoprotein D acquires mannose 6-phosphate residues and binds to mannose 6-phosphate receptors. J Biol Chem (1994) 1.57
Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J Virol (1990) 1.57
Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv Exp Med Biol (1992) 1.57
Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin. J Virol (1994) 1.53
The export pathway of the pseudorabies virus gB homolog gII involves oligomer formation in the endoplasmic reticulum and protease processing in the Golgi apparatus. J Virol (1990) 1.49
Herpes simplex virus type 1 and pseudorabies virus bind to a common saturable receptor on Vero cells that is not heparan sulfate. J Virol (1993) 1.45
Comparison of heparin-sensitive attachment of pseudorabies virus (PRV) and herpes simplex virus type 1 and identification of heparin-binding PRV glycoproteins. J Gen Virol (1990) 1.43
Truncation of the carboxy-terminal 28 amino acids of glycoprotein B specified by herpes simplex virus type 1 mutant amb1511-7 causes extensive cell fusion. J Virol (1993) 1.40
Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion. Virology (1992) 1.38
Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV. J Virol (1991) 1.38
Antigenic and immunogenic characteristics of bovine herpesvirus type-1 glycoproteins GVP 3/9 and GVP 6/11a/16, purified by immunoadsorbent chromatography. Virology (1985) 1.35
Identification of herpes simplex virus type 1 glycoproteins interacting with the cell surface. J Virol (1990) 1.34
Studies on reovirus receptors of L cells: virus binding characteristics and comparison with reovirus receptors of erythrocytes. Virology (1984) 1.29
Comparison of the bovine herpesvirus 1 gI gene and the herpes simplex virus type 1 gB gene. J Virol (1988) 1.25
Interaction of poliovirus with its cell surface binding site. Virology (1994) 1.16
Mapping of heparin-binding structures on bovine herpesvirus 1 and pseudorabies virus gIII glycoproteins. Virology (1993) 1.09
Characterization of a common high-affinity receptor for reovirus serotypes 1 and 3 on endothelial cells. J Virol (1989) 1.08
Heparin-binding domain of bovid herpesvirus 1 glycoprotein gIII. Arch Virol (1994) 0.93
Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine (1993) 0.89
Mechanisms of bovine herpesvirus type 1 neutralization by monoclonal antibodies to glycoproteins gI, gIII and gIV. J Gen Virol (1992) 0.86
Identification of a putative cellular receptor for bovine herpesvirus 1. J Gen Virol (1994) 0.83
The use of fluorescein isothiocyanate in the determination of the bacterial biomass of grassland soil. Can J Microbiol (1970) 3.62
Rotavirus isolation and cultivation in the presence of trypsin. J Clin Microbiol (1977) 2.99
HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene (2010) 2.91
Utilization of the rpoB gene as a specific chromosomal marker for real-time PCR detection of Bacillus anthracis. Appl Environ Microbiol (2001) 2.50
Immunization of calves against enterotoxigenic colibacillosis by vaccinating dams with purified K99 antigen and whole cell bacterins. Infect Immun (1979) 2.06
Defense mechanisms against bovine herpesvirus: relationship of virus-host cell events to susceptibility to antibody-complement cell lysis. Infect Immun (1975) 1.98
Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein. J Virol (1985) 1.97
Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol (1993) 1.92
Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology (1984) 1.81
Proteins Specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus). J Virol (1981) 1.80
Host responses to infectious bovine rhinotracheitis virus. III. Isolation and immunologic activities of bovine T lymphocytes. J Immunol (1974) 1.79
Host defense mechanisms against infectious bovine rhinotracheitis virus: in vitro stimulation of sensitized lymphocytes by virus antigen. Infect Immun (1974) 1.69
Agrobacterium tumefaciens-mediated transformation of yeast. Proc Natl Acad Sci U S A (1996) 1.68
cis-element combinations determine phenylalanine ammonia-lyase gene tissue-specific expression patterns. Plant Cell (1992) 1.60
HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb. Biochemistry (2003) 1.59
Protection of newborn calves against fatal multisystemic infectious bovine rhinotracheitis by feeding colostrum from vaccinated cows. Can J Vet Res (1987) 1.59
Antibody-dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erthrocyte and herpesvirus-infected bovine target cells. Infect Immun (1976) 1.59
A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine (1994) 1.58
Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J Virol (1990) 1.57
Hemagglutination and hemagglutination-inhibition studies with a strain of Nebraska calf diarrhea virus (bovine rotavirus). Intervirology (1978) 1.57
Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. Oncogene (2006) 1.56
Bovine herpesvirus-1 vaccination against experimental bovine herpesvirus-1 and Pasteurella haemolytica respiratory tract infection: onset of protection. Am J Vet Res (1982) 1.54
Comparison of rotavirus strains by hemagglutination inhibition. Can J Microbiol (1978) 1.52
Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Adv Virus Res (1995) 1.52
Effects of trans-Cinnamic Acid on Expression of the Bean Phenylalanine Ammonia-Lyase Gene Family. Plant Physiol (1990) 1.51
Synthesis and processing of bovine herpesvirus 1 glycoproteins. J Virol (1986) 1.51
All Brn3 genes can promote retinal ganglion cell differentiation in the chick. Development (2000) 1.48
Characterization of bovine herpesvirus 1 UL49 homolog gene and product: bovine herpesvirus 1 UL49 homolog is dispensable for virus growth. J Virol (1995) 1.48
A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc Natl Acad Sci U S A (1996) 1.44
Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b. Pediatr Res (1990) 1.43
Causes of childhood blindness in the People's Republic of China: results from 1131 blind school students in 18 provinces. Br J Ophthalmol (1999) 1.39
The effect of dose, route and virulence of bovine herpesvirus 1 vaccine on experimental respiratory disease in cattle. Can J Comp Med (1983) 1.39
Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV. J Virol (1991) 1.38
Cloning and in vitro expression of the gene for the E3 haemagglutinin glycoprotein of bovine coronavirus. J Gen Virol (1989) 1.37
Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins. Virology (1987) 1.36
Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women. J Bone Miner Res (1997) 1.36
Monoclonal antibodies to bovine coronavirus: characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins. Virology (1987) 1.35
Antigenic and immunogenic characteristics of bovine herpesvirus type-1 glycoproteins GVP 3/9 and GVP 6/11a/16, purified by immunoadsorbent chromatography. Virology (1985) 1.35
Host defense mechanisms against infectious bovine rhinotracheitis virus. II. Inhibition of viral plaque formation by immune peripheral blood lymphocytes. Cell Immunol (1975) 1.35
Mechanisms of resistant of herpesviruses: comparison of the effectiveness of different cell types in mediating antibody-dependent cell-mediated cytotoxicity. Infect Immun (1977) 1.34
Mechanisms of recovery from Herpesvirus infections -a review. Can J Comp Med (1978) 1.34
Further analysis of the role of calcium in rotavirus morphogenesis. Virology (1987) 1.32
Functional and topographical analyses of epitopes on bovine herpesvirus type 1 glycoprotein IV. Arch Virol (1988) 1.30
VirE1 is a specific molecular chaperone for the exported single-stranded-DNA-binding protein VirE2 in Agrobacterium. Mol Microbiol (1999) 1.30
Genetic heterogeneity within individual bovine rotavirus isolates. J Virol (1982) 1.29
Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses. Infect Immun (1976) 1.29
The role of antibody dependent cytotoxicity in recovery from herpesvirus infections. Cell Immunol (1976) 1.27
Analysis of bovine herpes virus-type 1 isolates by restriction endonuclease fingerprinting. Arch Virol (1983) 1.26
The interaction between bovine herpesvirus type 1 and activated bovine T lymphocytes. J Gen Virol (1990) 1.25
The direct antiviral cytotoxicity by bovine lymphocytes is not restricted by genetic incompatibility of lymphocytes and target cells. J Immunol (1977) 1.24
Phox homology domains specifically bind phosphatidylinositol phosphates. Biochemistry (2001) 1.24
Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone. Infect Immun (1980) 1.23
Effect of tunicamycin on rotavirus assembly and infectivity. J Virol (1982) 1.23
Topographical analysis of bovine herpesvirus type-1 glycoproteins: use of monoclonal antibodies to identify and characterize functional epitopes. Virology (1985) 1.22
An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J Infect Dis (1997) 1.22
Studies on rotaviral antibody in bovine serum and lacteal secretions, using radioimmunoassay. J Am Vet Med Assoc (1978) 1.22
ATF-7, a novel bZIP protein, interacts with the PRL-1 protein-tyrosine phosphatase. J Biol Chem (2001) 1.21
Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside. Antimicrob Agents Chemother (1975) 1.21
Agrobacterium VirD2 protein interacts with plant host cyclophilins. Proc Natl Acad Sci U S A (1998) 1.21
Phenylalanine ammonia-lyase gene organization and structure. Plant Mol Biol (1989) 1.21
Nuclear localization of the ORF2 protein encoded by porcine circovirus type 2. Virology (2001) 1.19
CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev (2001) 1.19
Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1. J Biol Chem (1998) 1.18
Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J Control Release (2000) 1.18
Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol (2001) 1.18
The role of neutrophils in antiviral defense--in vitro studies on the mechanism of antiviral inhibition. J Immunol (1977) 1.18
Antibody dependent cytotoxicity mediated by neutrophils: a possible mechanism of antiviral defense. J Reticuloendothel Soc (1976) 1.17
Biochemical evidence for the oligomeric arrangement of bovine rotavirus nucleocapsid protein and its possible significance in the immunogenicity of this protein. J Gen Virol (1987) 1.17
Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum (2001) 1.17
Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine (1993) 1.16
Bovine herpesvirus 1 UL49.5 homolog gene encodes a novel viral envelope protein that forms a disulfide-linked complex with a second virion structural protein. J Virol (1996) 1.16
Viral-bacterial pneumonia in calves: effect of bovine herpesvirus-1 on immunologic functions. J Infect Dis (1985) 1.15
The mammary gland of the ox: a convenient source for the repeated collection of neutrophils and macrophages. J Reticuloendothel Soc (1976) 1.15
Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Neuroscience (2006) 1.15
Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC(nectin-1) with different affinities. Virology (2001) 1.15
Expression of bovine herpesvirus 1 glycoproteins gI and gIII in transfected murine cells. J Virol (1988) 1.14
Prevention of experimental bovine pneumonic pasteurellosis with an extract of Pasteurella haemolytica. Can J Comp Med (1983) 1.14
Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology (2001) 1.14
Neutrophils in antiviral immunity: inhibition of virus replication by a mediator produced by bovine neutrophils. J Infect Dis (1980) 1.14
The Agrobacterium tumefaciens virulence gene chvE is part of a putative ABC-type sugar transport operon. J Bacteriol (1997) 1.14
Collapse of the N=28 shell closure in (42)Si. Phys Rev Lett (2007) 1.13
Quantitative, competitive PCR analysis of porcine circovirus DNA in serum from pigs with postweaning multisystemic wasting syndrome. J Clin Microbiol (2000) 1.13
Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine (1990) 1.13
The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J Virol (2002) 1.13
Chronic shedding of bovine enteric coronavirus antigen-antibody complexes by clinically normal cows. J Gen Virol (1985) 1.12
Structural proteins of bovine coronavirus and their intracellular processing. J Gen Virol (1987) 1.12
Induction of immune responses by DNA vaccines in large animals. Vaccine (2003) 1.12
Antiviral screening of British Columbian medicinal plants. J Ethnopharmacol (1995) 1.12
Replication-defective bovine adenovirus type 3 as an expression vector. J Virol (1999) 1.12